Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index; 55 of the 89 sources its claims cite were checked for support.

Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review

Open access
Ballesta, Francisco J. Gomez, Vásquez, Laurens N. Antonio, Borbón, Juliana Rey, Leal, Jefferson A. Casas, Agudelo, Danniel S. Jaramillo, Granados, Juan P. Alzate · 2025 · Journal of Musculoskeletal Surgery and Research

Abstract

Musculoskeletal injuries are a prevalent cause of disability, often impairing daily function and overall well-being. Standard treatments – including physiotherapy, anti-inflammatory medications, and surgery – frequently fall short in achieving optimal outcomes. Regenerative strategies, particularly platelet-rich plasma (PRP) and stem cell (SC) therapies, have emerged as alternatives due to their biological capacity to promote tissue regeneration and repair. This systematic review synthesizes evidence from randomized controlled trials that compare PRP and SC interventions with conventional management of musculoskeletal injuries. Literature was systematically searched in PubMed, Embase, and LILACS for relevant studies published through a structured search strategy. A total of 23 studies met the eligibility criteria. Findings indicate that PRP facilitates early pain relief and functional gains, while SC therapies contribute to sustained regenerative effects. When used in combination, PRP and SC demonstrated enhanced clinical outcomes. Although no serious adverse events were consistently reported, marked heterogeneity in protocols and outcomes was observed. Risk of bias varied across studies, highlighting the need for methodological rigor. Overall, the evidence suggests that PRP and SC therapies hold potential for musculoskeletal repair. However, standardized protocols and further robust clinical trials are essential to confirm their safety, efficacy, and broader applicability.

Overview

CoChat Summary

TL;DR

This systematic review of 23 randomized controlled trials found that platelet-rich plasma (PRP) and stem cell therapies generally improved pain and function more than conventional treatments for musculoskeletal injuries. The authors conclude these biologic therapies are promising, but heterogeneity and bias limit definitive conclusions.

Key findings

  • The search identified 437 records; after screening, 23 studies met inclusion criteria.
  • Across the included RCTs, PRP and/or stem cell therapies were associated with improvements in pain and function in several conditions, including knee osteoarthritis, rotator cuff tendinopathy, Achilles tendinopathy, and degenerative disc disease.
  • Reported effect estimates included, for example, MSC ± PRP vs corticosteroids in knee OA with pain reduction Δ23.2 (P < 0.001) and functional improvement Δ24.0 (P = 0.002) at 12 months, and PRP vs corticosteroids in high tibial osteotomy patients with global KOOS Δ +40 points (P < 0.05) and VAS Δ -5 points (P < 0.05).
  • Risk of bias was substantial: 10 studies (43.5%) were rated high risk of bias, and 13 (56.5%) had some concerns.

Methods

  • Systematic review conducted following PRISMA guidelines; included randomized controlled trials comparing PRP and/or mesenchymal stem cells with conventional treatments for musculoskeletal injury repair.
  • Databases searched: MEDLINE (PubMed), Embase, and LILACS; studies were limited to English and Spanish and reference lists were also checked.
  • Outcomes extracted included pain reduction, functional improvement, time to return to activity, adverse events, additional procedures, and quality of life; study quality was assessed with Cochrane RoB 2.0.

Limitations

  • The paper states that methodological limitations and protocol heterogeneity limit the ability to draw definitive conclusions.
  • The authors also note differences in PRP preparation, MSC sources, doses, delivery routes, and outcome measures, which limited comparability and pooled interpretation.
  • Evident from the text: nearly half of the included studies had high risk of bias (10/23), and the review restricted inclusion to English and Spanish studies, which may have excluded relevant evidence.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.25259/jmsr_402_2025

Cites

35 of 36 references verified0 citation errors · 1 not checkable

Statistics

Nothing to recompute.

Figures

Image 1
From the PDF
Image 2
From the PDF
Figure 1 PRISMA 2020 flow diagram illustrating the process of study selection. A total of 437 records were identified, of which 122 were screened after removing duplicates and ineligible records. Ultimately, 23 studies met the inclusion criteria and were included in the systematic review.
Figure 1 PRISMA 2020 flow diagram illustrating the process of study selection. A total of 437 records were identified, of which 122 were screened after removing duplicates and ineligible records. Ultimately, 23 studies met the inclusion criteria and were included in the systematic review.From the PDF

Verification

Claims the paper makes

49 Valid · 8 Not valid · 27 Not checked · 29 Own results and interpretations

75 more claims · 34 with their cited sources checked

Create a free account to see all 113 claims and to verify the 7 references still open.

See all claims — free account
  • It may state two separate claims as one. 13
  • The quote only partly states this claim. 11
  • Probably not a substantial claim. 12

Create a free account to see these claims.

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. Angoorani, 2015, Treatment of knee osteoarthritis with platelet-rich plasma in comparison with transcutaneous electrical nerve stimulation plus exercise: A randomized clinical trial, Med J Islam Repub Iran, 29, 223

Metadata

Authors
Ballesta, F. J. G., Vásquez, L. N. A., Borbón, J. R., Leal, J. A. C., Agudelo, D. S. J., & Granados, J. P. A.
Affiliations
  • Department of Epidemiology, Universidad Autonoma de Bucaramanga, Bogota, Colombia,
  • Universidad Industrial de Santander (CO)
  • Universidad de La Sabana (CO)
  • Universidad De Santander (CO)
  • Department of Medicine, Universidad Coperativa de Medellín, Medellín, Colombia,
  • Universidad Nacional de Colombia (CO)
Venue
Journal of Musculoskeletal Surgery and Research
Published
2025-12-30
Volume
10
Pages
138-146
ISSN
  • 2589-1219 (ISSN-L)
  • 2589-1227
OpenAlex
W7117533581
Cited by
0
References
30
FWCI
0.00
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
Journal of Musculoskeletal Surgery and Research (publishedVersion, cc-by-nc-sa)
Topics
  • Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
platelet-rich plasma, stem cell therapy, musculoskeletal injuries, tissue regeneration, regenerative medicine, conventional therapy comparison, analgesia, functional recovery, treatment protocols, treatment efficacy and safety

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review. https://app.cochat.ai/papers/10.25259/jmsr_402_2025
The paper
Ballesta, F. J. G., Vásquez, L. N. A., Borbón, J. R., Leal, J. A. C., Agudelo, D. S. J., & Granados, J. P. A. (2025). Management of platelet-rich plasma and stem cells versus conventional treatments in musculoskeletal injury repair: A systematic review. Journal of Musculoskeletal Surgery and Research. https://doi.org/10.25259/jmsr_402_2025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.